Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : AZNCF crawled time : 12:20 save search
Fortress Biotech to Present at the BTIG Virtual Biotechnology Conference 2023
Published: 2023-08-03 (Crawled : 12:20) - globenewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: 1.2%
H: 1.52%
C: -4.99%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -2.88%
H: 1.68%
C: 1.53%
conference biotech
Rallybio Announces Succession Plan; Appoints Stephen Uden, M.D., as Chief Executive Officer, Effective August 1, 2023
Published: 2023-06-29 (Crawled : 12:20) - biospace.com/
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 1.06%
H: 0.72%
C: 0.72%
RLYB | News | $1.75 4.79% 4.57% 310K
|
|
| O: -0.34%
H: 4.41%
C: -5.25%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.19%
H: 1.41%
C: 1.36%
CRL | $226.78 -0.34% 0.0% 410K
|
Commercial Services
|
| O: 0.09%
H: 1.73%
C: 1.58%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.83%
H: 0.89%
C: 0.68%
Urica Therapeutics Announces Topline Data from the Phase 1 Clinical Trial Evaluating Dotinurad in Healthy Volunteers in the United States
Published: 2023-06-29 (Crawled : 12:20) - globenewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 1.06%
H: 0.72%
C: 0.72%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: 0.0%
H: 7.55%
C: 7.55%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.83%
H: 0.89%
C: 0.68%
topline trial therapeutics
Helocyte Announces $3.22 Million Grant from the National Cancer Institute for Triplex Phase 2 Clinical Trial Program
Published: 2023-06-15 (Crawled : 12:20) - globenewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 0.97%
H: 0.64%
C: 0.64%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: 2.42%
H: 10.78%
C: 7.94%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.68%
H: 1.0%
C: 0.84%
cancer grant program trial phase 2
Artelo Biosciences Reports Fiscal 2022 Year-End Financial Results and Provides Business Update
Published: 2023-03-31 (Crawled : 12:20) - globenewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 0.62%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.98%
H: 0.07%
C: -0.67%
ARTL | $1.28 -1.94% 5.5K
|
Health Technology
|
| O: -3.26%
H: 12.98%
C: 11.54%
business update financial results
Flagship Pioneering Announces Appointment of Christian Schade as Growth Partner
Published: 2023-01-31 (Crawled : 12:20) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -1.05%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.19%
H: 1.07%
C: 1.06%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -1.22%
H: 0.52%
C: 0.51%
growth
Genprex Announces Safety Review Committee Approves Dose Escalation in Acclaim-1 Phase 1/2 Trial of REQORSA™ in Combination with Tagrisso® in Non-Small Cell Lung Cancer
Published: 2022-08-15 (Crawled : 12:20) - biospace.com/
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 3.35%
H: 0.0%
C: -0.09%
GNPX | $2.2194 -2.31% 38K
|
Health Technology
|
| O: 7.91%
H: 13.09%
C: 9.42%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.92%
H: 0.22%
C: -0.65%
tagrisso lung trial review cancer phase 1
Artelo Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
Published: 2022-08-09 (Crawled : 12:20) - globenewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -3.88%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.23%
H: 0.77%
C: -0.05%
ARTL | $1.28 -1.94% 5.5K
|
Health Technology
|
| O: -8.28%
H: 2.62%
C: -16.76%
update results
Valued to be $12.9 Billion by 2026, Crohn`s Disease (CD) Therapy Slated for Robust Growth Worldwide
Published: 2022-06-27 (Crawled : 12:20) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -1.55%
H: 4.43%
C: 0.03%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 1.46%
H: 1.45%
C: 0.78%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.86%
H: 1.05%
C: 0.24%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.78%
H: 0.94%
C: 0.26%
CCXI | $51.99 -0.04%
|
Health Technology
|
| O: -4.88%
H: 1.04%
C: -1.25%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.36%
H: 1.22%
C: 0.38%
disease therapy growth
Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Report 2022 with Competitive Landscape Analysis of Eli Lily and Co; Novartis; Bristol-Myers Squibb; Roche Diagnostics; Sanofi
Published: 2022-06-17 (Crawled : 12:20) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.01%
H: 0.17%
C: 0.17%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.76%
H: 5.75%
C: 5.5%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: -0.64%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.74%
H: 0.52%
C: -3.23%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.07%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.24%
H: 0.0%
C: 0.0%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.39%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.59%
H: 0.0%
C: 0.0%
active report roche sanofi market diagnostic
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.